Vinyas Says US Exposure Near 20% and Export Margins Higher
Key highlights
- Vinyas said US-market exposure was close to 20% of revenue on November 12, 2026.
- Vinyas said the new US manufacturing entity had been incorporated only three or four months earlier.
- Management said export margins are usually better than domestic margins, with a gradual effect expected primarily in FY29.
- Vinyas expects its 25,000-square-foot Mysore system-integration expansion to be ready by the end of the financial year.
powered by IRIS

Vinyas Innovative Technologies Limited said on November 12, 2026 that its US-market exposure was close to 20% of revenue, while management said export margins are usually better than domestic margins. The company distinguished that existing exposure from its new US joint-venture manufacturing facility, which had operated for only three or four months and is expected to contribute more from FY28.
Know Vinyas Innovative Technologies inside out
Results, valuation, peers and who's buying, in one view.
What does Vinyas's close-to-20% US exposure represent?
Vinyas said the close-to-20% figure represents exposure to the US market, not revenue produced at its newly incorporated US facility. Management made that distinction when asked about US business, describing the facility itself as very small because the entity had been incorporated only three or four months earlier. The company therefore has US-market exposure that predates material output from the new facility.
The 20% measure should not be read as the current sales contribution of the US factory. Vinyas said it expects a larger portion of its US exposure to come through that facility in FY28. The US operation is a joint venture, or JV, intended for local US programmes and export-restricted programmes, while non-restricted portions are intended to be manufactured at the Mysore facility.
Why does Vinyas expect exports to improve margins?
Vinyas said export margins are slightly, or usually, better than domestic margins. Management did not disclose the numerical difference, but said the benefit from increasing export business would transition slowly and would be primarily visible in FY29 rather than immediately in FY28. The margin effect therefore depends on the pace of the business-mix change.
The US opportunity forms part of Vinyas's broader shift from printed circuit board assembly, or PCBA, to subsystem and system-level manufacturing. Management said subsystem manufacturing would remain the larger portion of that work. It expects a dedicated 25,000-square-foot floor in Mysore to be ready by the end of the financial year to serve mechanical and system-integration requirements that are currently handled on the existing manufacturing floor.
Management linked the changing mix to its internal target of reaching mid-teens earnings before interest, tax, depreciation and amortisation, or EBITDA, margins in three to four years. It cited system integration, value mix, US-market exposure and new geographies as the mechanisms behind that target. This is a management objective rather than reported guidance for a specified year, and management placed the more material export-related improvement primarily in FY29.
Will the US and Indian JVs move Mysore revenue away?
Vinyas said no existing standalone programme or revenue is expected to move to either JV. Management said electronics manufacturing would continue at Vinyas and described the US JV as a means of expanding access to the US market, rather than transferring the Indian manufacturing base. Non-restricted content from US programmes is intended to return to Mysore for manufacture.
The US JV will undertake local US programmes and export-restricted work that needs to be performed in the United States. Management said its capabilities and manufacturing processes would be a subset of those at Vinyas. This limits the stated scope of the US facility relative to the company's India operations, even as it creates a local route for restricted programmes.
For the other JV, which management described as a Tier 1 supplier to Indian defence, Vinyas expects to supply electronics systems and subsystems. Management agreed with an analyst that the two JVs should create a new order-book funnel for Vinyas. It did not provide an outlook for the Indian JV because the facility remains confidential and is still being set up, although it said it may comment later in the year.
Got a follow-up? Ask IRIS
When could the US facility add more business?
Vinyas said the US facility should make a larger contribution from FY28 after its initial three-to-four-month incorporation period. Management described it as a contract-manufacturing operation focused initially on PCBA and subsystem manufacturing for US customers. It said the first stage of the facility plan covers infrastructure and upgrades, which it expected to complete by the end of the calendar year.
Vinyas holds a 49% stake in the US JV and said it is contributing manufacturing know-how and processes. Management tied its longer-term expectations for the facility to the two manufacturing lines and installed capacity, but characterised those expectations as an outlook rather than reported revenue. The distinction is relevant because the close-to-20% US exposure currently includes market exposure beyond the new US facility.
In Mysore, the 25,000-square-foot system-integration expansion is intended to support system-level manufacturing and back-end operations, rather than alter Vinyas's stated medium-term growth range. Management continued to expect 30% to 35% growth through FY30, while saying the floor addresses the mix of work. It estimated capital expenditure for the expansion at Rs 2 crore to Rs 3 crore, mainly for existing-building work and mechanical-assembly workstations rather than new machinery.
Conclusion
Vinyas's US strategy has two separate elements: US-market exposure that was already close to 20% of revenue on November 12, 2026, and a new US manufacturing JV that management expects to contribute more from FY28. Management's case for higher margins rests on export economics, more system-integration work and a reduced reliance on a PCBA-heavy mix, while non-restricted programme content is intended to remain in Mysore.
The next disclosed milestones are completion of the US-facility upgrade by the end of the calendar year and readiness of the 25,000-square-foot Mysore floor by the end of the financial year. Investors can also watch whether the anticipated FY28 increase in US-facility activity supports the gradual margin transition that management said would be primarily evident in FY29, alongside its 30% to 35% growth expectation through FY30.


